Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1979 1
1980 3
1981 6
1982 7
1983 6
1984 2
1985 4
1986 17
1987 8
1988 10
1989 12
1990 21
1991 18
1992 25
1993 42
1994 42
1995 43
1996 60
1997 56
1998 82
1999 89
2000 95
2001 132
2002 163
2003 211
2004 237
2005 328
2006 358
2007 421
2008 468
2009 546
2010 708
2011 769
2012 875
2013 1056
2014 1267
2015 1403
2016 1503
2017 1575
2018 1768
2019 1990
2020 2260
2021 2590
2022 3041
2023 3133
2024 3597
2025 3351
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30,894 results

Results by year

Filters applied: . Clear all
Page 1
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.
Jiang J, Jiang L, Maldonato BJ, Wang Y, Holderfield M, Aronchik I, Winters IP, Salman Z, Blaj C, Menard M, Brodbeck J, Chen Z, Wei X, Rosen MJ, Gindin Y, Lee BJ, Evans JW, Chang S, Wang Z, Seamon KJ, Parsons D, Cregg J, Marquez A, Tomlinson ACA, Yano JK, Knox JE, Quintana E, Aguirre AJ, Arbour KC, Reed A, Gustafson WC, Gill AL, Koltun ES, Wildes D, Smith JAM, Wang Z, Singh M. Jiang J, et al. Cancer Discov. 2024 Jun 3;14(6):994-1017. doi: 10.1158/2159-8290.CD-24-0027. Cancer Discov. 2024. PMID: 38593348 Free PMC article.
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial.
Yue D, Wang W, Liu H, Chen Q, Chen C, Liu L, Zhang P, Zhao G, Yang F, Han G, Cheng Y, Yu B, Yang Y, Chen H, Jiang J, Tan L, Xu S, Mao N, Hu J, Zhang L, Yao B, Wang S, Wang RH, Zheng W, Wang C; RATIONALE-315 investigators. Yue D, et al. Among authors: jiang j. Lancet Respir Med. 2025 Feb;13(2):119-129. doi: 10.1016/S2213-2600(24)00269-8. Epub 2024 Nov 21. Lancet Respir Med. 2025. PMID: 39581197 Clinical Trial.
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI.
Koo BK, Hu X, Kang J, Zhang J, Jiang J, Hahn JY, Nam CW, Doh JH, Lee BK, Kim W, Huang J, Jiang F, Zhou H, Chen P, Tang L, Jiang W, Chen X, He W, Ahn SG, Yoon MH, Kim U, Lee JM, Hwang D, Ki YJ, Shin ES, Kim HS, Tahk SJ, Wang J; FLAVOUR Investigators. Koo BK, et al. Among authors: jiang j. N Engl J Med. 2022 Sep 1;387(9):779-789. doi: 10.1056/NEJMoa2201546. N Engl J Med. 2022. PMID: 36053504 Clinical Trial.
Suzetrigine for moderate to severe acute pain.
Cho EB, Jiang C, Wang Z, Yu Y, Jiang J. Cho EB, et al. Among authors: jiang j. Trends Pharmacol Sci. 2025 May;46(5):480-481. doi: 10.1016/j.tips.2025.02.008. Epub 2025 Mar 24. Trends Pharmacol Sci. 2025. PMID: 40133193
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.
Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, Heeley E, Skulina C, Parsons MW, Kim JS, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Heritier S, Morgenstern LB, Chalmers J; INTERACT Investigators. Anderson CS, et al. Among authors: jiang jd. Lancet Neurol. 2008 May;7(5):391-9. doi: 10.1016/S1474-4422(08)70069-3. Epub 2008 Apr 7. Lancet Neurol. 2008. PMID: 18396107 Clinical Trial.
Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study.
Xu JF, Zheng HZ, Lu HW, Wang LW, Wu B, Lv XD, Luo H, Feng J, Li YY, Liu L, Jia JG, Mo WQ, Gu HY, Jiang JB, Wang DX, Wang B, Li L, Yuan Z, Li W, Xie M, Jie ZJ, Fan XY, Li D, Tian X, Zhang M, Guan WJ, Fan H, Song YL, He J, Chu DJ, Du CL, Zhang JQ, Cao C, Qu JM, Chalmers JD; BE-China Registry Investigators. Xu JF, et al. Among authors: jiang jb. Lancet Respir Med. 2025 Feb;13(2):166-176. doi: 10.1016/S2213-2600(24)00364-3. Epub 2025 Jan 10. Lancet Respir Med. 2025. PMID: 39805296 Free article.
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis.
Zhang XJ, Fu J, Cheng X, Shen H, Yang H, Wang K, Li W, Tian H, Tian T, Zhou J, Tian S, Wang Z, Wan J, Bai L, Duan H, Zhang X, Tian R, Xu H, Liao R, Zou T, Shi J, Qu W, Fang L, Cai J, Zhang P, She ZG, Jiang J, Hu Y, Wang Y, Li H. Zhang XJ, et al. Among authors: jiang j. J Clin Invest. 2025 Sep 2;135(17):e173193. doi: 10.1172/JCI173193. eCollection 2025 Sep 2. J Clin Invest. 2025. PMID: 40892510 Free PMC article.
30,894 results
You have reached the last available page of results. Please see the User Guide for more information.